Monti (China) Pharmaceutical Co., Ltd.

On June 5438+00, 2006, it purchased shares and became a wholly-owned company. 20 10 invested $20 million in Zhongguancun Science Park Tongzhou Park Jinqiao Science and Technology Industrial Base to build a world-class new factory. 20 10 May, it was officially renamed as Monti (China) Pharmaceutical Co., Ltd.

Monti (China) Pharmaceutical Co., Ltd. is one of the designated manufacturers of narcotic and analgesic drugs in China. The company has a highly automated production line for special tablets, adopts the world-class controlled release technology of NAPP Company of the United Kingdom under Monti International Group, and produces analgesic drugs covering every step of the three-step cancer analgesic scheme in strict accordance with GMP standards. Such as mescandine (morphine sulfate controlled-release tablets), oxycodone hydrochloride controlled-release tablets, zimandine (tramadol hydrochloride sustained-release tablets), estastatin and so on. Three-step analgesic scheme for cancer is recommended by the World Health Organization and widely used all over the world. Monti International Group has more than 65,438+000 manufacturers and branches of narcotic and analgesic drugs in the world, and is one of the largest independent pharmaceutical companies in the world.